Intuitive Surgical, Inc.  

(Public, NASDAQ:ISRG)   Watch this stock  
Find more results for Eric Friedman´┐Ż
+1.37 (0.26%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 516.88 - 521.05
52 week 447.00 - 564.86
Open 519.10
Vol / Avg. 77,594.00/338,527.00
Mkt cap 19.35B
P/E 35.89
Div/yield     -
EPS 14.47
Shares 37.37M
Beta 0.70
Inst. own 92%
Jan 20, 2016
Q4 2015 Intuitive Surgical Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 17, 2015
Intuitive Surgical Inc at Stifel Healthcare Conference
Oct 20, 2015
Q3 2015 Intuitive Surgical Inc Earnings Call - Webcast
Oct 20, 2015
Q3 2015 Intuitive Surgical Inc Earnings Release
Sep 18, 2015
Intuitive Surgical Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 28.37% 19.65%
Operating margin 32.20% 25.56%
EBITD margin - 29.05%
Return on average assets 14.85% 10.59%
Return on average equity 16.97% 12.17%
Employees 2,978 -
CDP Score - -


1020 Kifer Rd
SUNNYVALE, CA 94086-5301
United States - Map
+1-408-5232100 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Intuitive Surgical, Inc. designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation and three-dimensional (3-D), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery, gynecologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.

Officers and directors

Lonnie M. Smith Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gary S. Guthart Ph.D. President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Marshall L. Mohr Chief Financial Officer, Senior Vice President
Age: 59
Bio & Compensation  - Reuters
Salvatore J. Brogna Executive Vice President - Product Operations
Age: 60
Bio & Compensation  - Reuters
David J. Rosa Executive Vice President, Chief Commercial Officer
Age: 47
Bio & Compensation  - Reuters
Mark J. Meltzer Senior Vice President, General Counsel
Age: 65
Bio & Compensation  - Reuters
Myriam J. Curet Senior Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Colin Morales Senior Vice President - Manufacturing and Service Operations
Age: 51
Bio & Compensation  - Reuters
Jamie E. Samath Vice President, Corporate Controller, and Principal Accounting Officer
Age: 44
Bio & Compensation  - Reuters
Michael A. Friedman M.D. Director
Age: 70
Bio & Compensation  - Reuters